Novo Holdings A/S Q4 2017 Filing
Filed February 14, 2018
Portfolio Value
$713.4B
Holdings
14
Report Date
Q4 2017
Filing Type
13F-HR
All Holdings (14 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | INGNINOGEN INC | 3,549,320 | $422.7B | 59.25% | |
| 2 | XLRNACCELERON PHARMA INC | 1,553,937 | $65.9B | 9.24% | |
| 3 | —DERMIRA INC | 1,984,364 | $55.2B | 7.74% | |
| 4 | CRVSCORVUS PHARMACEUTICALS INC | 3,244,046 | $33.6B | 4.71% | |
| 5 | AKBAAKEBIA THERAPEUTICS INC | 2,225,000 | $33.1B | 4.64% | |
| 6 | MRUSMERUS N V | 1,410,417 | $27.4B | 3.84% | |
| 7 | —NABRIVA THERAPEUTICS PLC | 2,924,822 | $17.5B | 2.45% | |
| 8 | —RA PHARMACEUTICALS INC | 2,031,562 | $17.3B | 2.42% | |
| 9 | VRNAVERONA PHARMA PLC | 740,740 | $8.8B | 1.23% | |
| 10 | —INVUITY INC | 1,363,848 | $8.5B | 1.19% | |
| 11 | KIDSORTHOPEDIATRICS INC | 379,014 | $7.3B | 1.02% | |
| 12 | —WRIGHT MED GROUP N V | 4,622,032 | $7.0B | 0.98% | |
| 13 | CRSPCRISPR THERAPEUTICS AG | 223,317 | $5.2B | 0.73% | |
| 14 | GKOSGLAUKOS CORP | 156,429 | $4.0B | 0.56% |